Publications

2018

  1. Iris C. Salaroglio; Elena Gazzano; Ahmad Abdullrahman et_al. (2018). Increasing intratumor C/EBP- LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.  Journal Of Experimental & Clinical Cancer Research. 37.  Abstract
  2. Joanna Kopecka; Iris C. Salaroglio; Luisella Righi et_al. (2018). Loss of C/EBP-beta LIP drives cisplatin resistance in malignant pleural mesothelioma.  Lung Cancer. 120:34-45.  Abstract
  3. Menachem Rubinstein (2018). Is Lgr4 essential for VSV- and VSV-G-pseudotyped lentiviral vector entry to cells?.  The journal of Biological chemistry. 293:(1)112-112.
  4. Menachem Rubinstein; Efrat Dvash (2018). Leukotrienes and kidney diseases.  Current Opinion in Nephrology and Hypertension. 27:(1)42-48.  Abstract

2017

  1. Iris C. Salaroglio; Elisa Panada; Enrico Moiso; Ilaria Buondonno; Paolo Provero; Menachem Rubinstein; Joanna Kopecka; Chiara Riganti (2017). PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.  Molecular Cancer. 16.
  2. Dozorets, Rina Wassermann Dozorets; Menachem Rubinstein (2017). C/EBP beta LIP augments cell death by inducing osteoglycin.  Cell Death & Disease. 8.  Abstract

2016

  1. J Kobecka; E Panda; IC Salaroglio; I Buondonno; Shmuel Barak; Menachem Rubinstein; C Riganti (2016). C/EBP-beta-LIP turnover decides cancer chemotherapy outcome.  European Journal of Cancer. 68:S71-S71.  Abstract
  2. Efrat Dvash; Menachem Rubinstein (2016). A surprising mediator of oxidative DNA damage.  Cell cycle (Georgetown, Tex.). 15:(7)869-70.

2015

  1. Efrat Dvash; Michal Har-Tal; Sara Barak; Ofir Meir; Menachem Rubinstein (2015). Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage.  Nature Communications. 6:10112-10112.  Abstract
  2. Chiara Riganti; Joanna Kopecka; Elisa Panada; Sara Barak; Menachem Rubinstein (2015). The Role of C/EBP-beta LIP in Multidrug Resistance.  JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 107:(5)  Abstract

2014

  1. Tali Garin-Shkolnik; Assaf Rudich; Goekhan S. Hotamisligil; Menachem Rubinstein (2014). FABP4 Attenuates PPAR gamma and Adipogenesis and Is Inversely Correlated With PPARg in Adipose Tissues.  Diabetes. 63:(3)900-911.

2013

  1. Danit Finkelshtein; Ariel Werman; Daniela Novick; Sara Barak; Menachem Rubinstein (2013). LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus.  Proceedings of the National Academy of Sciences of the United States of America. 110:(18)7306-7311.  Abstract

2012

  1. Yoram Shechter; Keren Sasson; Goldman, Vered Lev Goldman; Sara Rubinraut; Menachem Rubinstein; Mati Fridkin (2012). Newly Designed Modifier Prolongs the Action of Short-Lived Peptides and Proteins by Allowing Their Binding to Serum Albumin.  Bioconjugate Chemistry. 23:(8)1577-1586.  Abstract
  2. Daniela Novick; Menachem Rubinstein (2012). Ligand Affinity Chromatography, an Indispensable Method for the Purification of Soluble Cytokine Receptors and Binding Proteins.  Cytokine Protocols. 195-214.  Abstract

2011

  1. Wenyong Zhang; M. Lin; A. Winesett et_al. (2011). The use of functionalized nanoparticles as non-specific compatibilizers for polymer blends.  Polymers for Advanced Technologies. 22:(1)65-71.  Abstract

2010

  1. Ofir Meir; Efrat Dvash; Ariel Werman; Menachem Rubinstein (2010). C/EBP-beta Regulates Endoplasmic Reticulum Stress-Triggered Cell Death in Mouse and Human Models.  PLoS One. 5:(3)  Abstract
  2. Daniela Novick; Daniel Elbirt; Galit Miller; Charles A. Dinarello; Menachem Rubinstein; Zev M. Sthoeger (2010). High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein.  Journal of Autoimmunity. 34:(2)121-126.  Abstract

2009

  1. Daniela Novick; D. Elbirt; C. A. Dinarello; Menachem Rubinstein; Z. M. Sthoeger (2009). Interleukin-18 Binding Protein in the Sera of Patients with Wegener's Granulomatosis.  Journal of Clinical Immunology. 29:(1)38-45.  Abstract

2008

  1. Ariel Werman; Ben Alkahe; Charles A. Dinarello; Menachem Rubinstein (2008). A role for intra-cellular interleukin-1alpha in antiviral defense.  Cytokine. 43:(3)307-307.  Abstract
  2. Ariel Werman; Brent E. Korba; Ben Alkahe; Danit Finkelshtein; Sergey Bujanover; Daniela Novick; Ernest Vinocour; Menachem Rubinstein (2008). A soluble form of the LDL receptor inhibits hepatitis B virus replication in vitro.  Cytokine. 43:(3)249-249.  Abstract

2007

  1. Simon R. Thompson; Daniela Novick; Carmel J. Stock et_al. (2007). Free interleukin (IL)-18 levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men.  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 27:(12)2743-2749.  Abstract
  2. Daniela Novick; Menachem Rubinstein (2007). The tale of soluble receptors and binding proteins: From bench to bedside.  Cytokine & Growth Factor Reviews. 18:(6-May)525-533.  Abstract
  3. Menachem Rubinstein (2007). The purification and characterization of alpha interferons and related cytokine receptors - A personal account.  Cytokine & Growth Factor Reviews. 18:(6-May)519-524.  Abstract
  4. Asaf Spiegel; Shoham Shivtiel; Alexander Kalinkovich et_al. (2007). Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34(+) cells through Wnt signaling.  Nature Immunology. 8:(10)1123-1131.  Abstract
  5. Vladimir Hurgin; Daniela Novick; Ariel Werman; Charles A. Dinarello; Menachem Rubinstein (2007). Antiviral and immunoregulatory activities of IFN-alpha depend on constitutively expressed IL-1 alpha.  Journal of Interferon and Cytokine Research. 27:(8)735-735.  Abstract
  6. Timna Naftali; Daniella Novick; Gila Gabay; Menahem Rubinstein; Ben Novis (2007). Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remissio and exacerbation.  Israel Medical Association Journal. 9:(7)504-508.  Abstract
  7. Vladimir Hurgin; Daniela Novick; Ariel Werman; Charles A. Dinarello; Menachem Rubinstein (2007). Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1 alpha.  Cytokine. 39:(1)17-17.  Abstract
  8. S. R. Thompson; Daniela Novick; C. Stock; Menachem Rubinstein; P. Woo; S. E. Humphries; J. Sanders (2007). Variation within IL18 but not IL18BP influences free IL-18 levels at baseline and during post-operative stress.  Atherosclerosis Supplements. 8:(1)52-52.  Abstract
  9. Ruth Z. Birk; Menachem Rubinstein (2007). Leptin restores plasma cholesterol, glucose and weight loss induced by IFN alpha treatment.  Biochemical and Biophysical Research Communications. 355:(3)626-631.  Abstract
  10. Vladimir Hurgin; Daniela Novick; Ariel Werman; Charles A. Dinarello; Menachem Rubinstein (2007). Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1 alpha.  Proceedings of the National Academy of Sciences of the United States of America. 104:(12)5044-5049.  Abstract

2006

  1. RZ Birk; Menachem Rubinstein (2006). IFN-alpha induces apoptosis of adipose tissue cells.  Biochemical and Biophysical Research Communications. 345:(2)669-674.  Abstract
  2. Daniela Novick; Menachem Rubinstein; T Azam; Aharon Rabinkov; CA Dinarello; SH Kim (2006). Proteinase 3 is an IL-32 binding protein.  Proceedings of the National Academy of Sciences of the United States of America. 103:(9)3316-3321.  Abstract

2005

  1. G Neumayr; O Ludwiczek; H Hoertnagl; R Pfister; G Mitterbauer; A Moschen; Daniela Novick; Menachem Rubinstein; H Tilg (2005). The impact of prolonged strenuous endurance exercise on interleukin 18 and interleukin 18 binding protein in recreational cyclists.  International Journal of Sports Medicine. 26:(10)836-840.  Abstract
  2. K Mazodier; V Marin; Daniela Novick et_al. (2005). Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome.  Blood. 106:(10)3483-3489.  Abstract
  3. Yoram Shechter; H Tsubery; M Mironchik; Menachem Rubinstein; Matityahu Fridkin (2005). Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.  FEBS Letters. 579:(11)2439-2444.  Abstract
  4. O Ludwiczek; A Kaser; Daniela Novick; CA Dinarello; Menachem Rubinstein; H Tilg (2005). Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease.  European Cytokine Network. 16:(1)27-33.  Abstract

2004

  1. G Gutman; J Har-Toov; A Many; JB Lessing; Daniela Novick; Menachem Rubinstein; AJ Jaffa (2004). Second-trimester amniotic fluid and maternal serum interleukin-18 binding protein levels.  American Journal of Obstetrics and Gynecology. 191:(6)S152-S152.  Abstract
  2. Dana Barkan; V Hurgin; Nava Dekel; Abraham Amsterdam; Menachem Rubinstein (2004). Leptin induces ovulation in GnRH-deficient mice.  FASEB Journal. 18:(13)133-+.  Abstract
  3. O Shevah; Menachem Rubinstein; Z Laron (2004). Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: Relationship between defects and ethnic groups.  Israel Medical Association Journal. 6:(10)630-633.  Abstract
  4. M Kawashima; Daniela Novick; Menachem Rubinstein; P Miossec (2004). Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis.  Arthritis and Rheumatology. 50:(6)1800-1805.  Abstract
  5. O Shevah; A Galli-Tsinopoulou; Menachem Rubinstein; S Nousia-Arvanitakis; Z Laron (2004). Classical phenotype of Laron syndrome in a girl with a heterozygous mutation and heterozygous polymorphism of the growth hormone receptor gene.  Journal Of Pediatric Endocrinology & Metabolism. 17:(3)371-374.  Abstract
  6. K Tomiyama; FN McNamara; JJ Clifford et_al. (2004). Comparative phenotypic resolution of spontaneous D(2)-like and D(1)-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D(2) vs. D(3) receptor "knockout".  Synapse. 51:(1)71-81.  Abstract

2003

  1. T Azam; Daniela Novick; P Bufler; DY Yoon; Menachem Rubinstein; CA Dinarello; SH Kim (2003). Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex.  Journal of Immunology. 171:(12)6574-6580.  Abstract
  2. G Lonnemann; Daniela Novick; Menachem Rubinstein; CA Dinarello (2003). Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure.  Clinical Nephrology. 60:(5)327-334.  Abstract
  3. RJ Feezor; C Oberholzer; HV Baker et_al. (2003). Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria.  Infection and Immunity. 71:(10)5803-5813.  Abstract
  4. O Shevah; P Borrelli; Menachem Rubinstein; Z Laron (2003). Identification of two novel mutations in the human growth hormone receptor gene.  Journal of Endocrinological Investigation. 26:(7)604-608.  Abstract
  5. S Gangemi; G Basile; RA Merendino et_al. (2003). Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity?.  Experimental Gerontology. 38:(6)669-672.  Abstract
  6. O Shevah; Menachem Rubinstein; Z Laron (2003). Molecular defects in the growth hormone receptor of Laron syndrome patients studied in Israel including three novel mutations.  Pediatric Research. 53:(4)150A-150A.  Abstract
  7. RJL Stuyt; SH Kim; LL Reznikov et_al. (2003). Regulation of Staphylococcus epidermidis-induced IFN-7 in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF.  Cytokine. 21:(2)65-73.  Abstract
  8. G Lonnemann; Daniela Novick; Menachem Rubinstein; J Passlick-Deetjen; D Lang; CA Dinarello (2003). A switch to high-flux Helixone (R) membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis.  Blood Purification. 21:(3)225-231.  Abstract
  9. CA Dinarello; Daniela Novick; Menachem Rubinstein; G Lonnemann (2003). Interleukin 18 and interleukin 18 binding protein: Possible role in immunosuppression of chronic renal failure.  Blood Purification. 21:(3)258-270.  Abstract
  10. RL Nolsoe; F Pociot; Daniela Novick; Menachem Rubinstein; SH Kim; CA Dinarello; T Mandrup-Poulsen (2003). Mutation scan of a type 1 diabetes candidate gene - The human interleukin-18 binding protein gene.  Immunology Of Diabetes Ii: Pathogenesis From Mouse To Man. 1005:332-339.  Abstract

2002

  1. V Hurgin; Daniela Novick; Menachem Rubinstein (2002). The promoter of IL-18 binding protein: Activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta.  Proceedings of the National Academy of Sciences of the United States of America. 99:(26)16957-16962.  Abstract
  2. Y Sandowski; N Raver; EE Gussakovsky; S Shochat; Orly Dym; O Livnah; Menachem Rubinstein; R Krishna; A Gertler (2002). Subcloning, expression, purification, and characterization of recombinant human leptin-binding domain.  Journal of Biological Chemistry. 277:(48)46304-46309.  Abstract
  3. O Ludwiczek; A Kaser; Daniela Novick; CA Dinarello; Menachem Rubinstein; W Vogel; H Tilg (2002). Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.  Journal of Clinical Immunology. 22:(6)331-337.  Abstract
  4. R Nolsoe; F Pociot; Daniela Novick; Menachem Rubinstein; SH Kim; CA Dinarello; T Mandrup-Poulsen (2002). Mutation scan of the human interleukin-18 binding protein: A candidate gene for type 1 (insulin dependent) diabetes.  American Journal of Human Genetics. 71:(4)478-478.  Abstract
  5. Benedetti, F De Benedetti; C Meazza; A Martini; Daniela Novick; Menachem Rubinstein; CA Dinarello (2002). Interleukin-18 (IL-18) and IL-18 binding protein (IL-18BP) in patients with juvenile idiopathic arthritis.  Arthritis and Rheumatology. 46:(9)S473-S473.  Abstract
  6. I Yatsiv; MC Morganti-Kossmann; D Perez et_al. (2002). Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury.  Journal of Cerebral Blood Flow and Metabolism. 22:(8)971-978.  Abstract
  7. A Kaser; Daniela Novick; Menachem Rubinstein et_al. (2002). Interferon-alpha induces interieukin-18 binding protein in chronic hepatitis C patients.  Clinical and Experimental Immunology. 129:(2)332-338.  Abstract
  8. A Ariel; Daniela Novick; Menachem Rubinstein; CA Dinarello; O Lider; R Hershkoviz (2002). IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components.  Journal of Leukocyte Biology. 72:(1)192-198.  Abstract
  9. O Shevah; O Nunez; Menachem Rubinstein; Z Laron (2002). Intronic mutation in the growth hormone receptor gene in a Peruvian girl with Laron syndrome.  Journal Of Pediatric Endocrinology & Metabolism. 15:(7)1039-1040.
  10. SH Kim; T Azam; Daniela Novick; DY Yoon; LL Reznikov; P Bufler; Menachem Rubinstein; CA Dinarello (2002). Identification of amino acid residues critical for biological activity in human interleukin-18.  Journal of Biological Chemistry. 277:(13)10998-11003.  Abstract
  11. K Tomiyama; J Clifford; F McNamara et_al. (2002). Analysis of dopamine D-1A, D-2 and D-3 receptor involvement in drug-induced orofacial movements using knockout mice.  Japanese Journal of Pharmacology. 88:190P-190P.  Abstract

2001

  1. G Zecchina; Daniela Novick; Menachem Rubinstein; Vered Barak; C Dinarello; A Nagler (2001). Cutting edge communication - Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants.  Journal Of Hematotherapy & Stem Cell Research. 10:(6)769-776.  Abstract
  2. I Yatsiv; P Stahel; Daniela Novick; Menachem Rubinstein; CA Dinarello; C Morganti-Kossmann; T Kossmann; E Shohami (2001). Elevated intracranial interleukin 18 levels after closed head injury in humans and mice: Evidence of neuroprotective effects of interleukin 18 binding protein after experimental brain injury.  Critical Care Medicine. 29:(12)A22-A22.  Abstract
  3. B Almog; R Gold; K Tajima et_al. (2001). Leptin attenuates follicular apoptosis and accelerates the onset of puberty in immature rats.  Molecular and Cellular Endocrinology. 183:(2-Jan)179-191.  Abstract
  4. I Yatsiv; PF Stahel; Daniela Novick; Menachem Rubinstein; CA Dinarello; MC Marganti-Kossmann; T Morganti-Kossmann; E Shohami (2001). Elevated intracranial interleukin-18 levels after closed head injury in humans and mice: Evidence of neuroprotection by interleukin-18-binding-protein after experimental head injury.  Intensive Care Medicine. 27:S287-S287.  Abstract
  5. RJL Stuyt; MG Netea; SH Kim; Daniela Novick; Menachem Rubinstein; BJ Kullberg; der Meer, JWM Van der Meer; CA Dinarello (2001). Differential roles of interleukin-18 (IL-18) and IL-12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.  Infection and Immunity. 69:(8)5025-5030.  Abstract
  6. Daniela Novick; B Schwartsburd; R Pinkus et_al. (2001). A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18.  Cytokine. 14:(6)334-342.  Abstract
  7. A Kaser; W Vogel; Daniela Novick; Menachem Rubinstein; CA Dinarello; H Tilg (2001). Interferon-alpha therapy and the IL-18 pathway in chronic hepatitis C patients: IFN-alpha therapy enhances circulating IL-18 binding protein levels.  Gastroenterology. 120:(5)A568-A568.  Abstract
  8. T Arazi; SG Slutsky; YM Shiboleth; YZ Wang; Menachem Rubinstein; Shmuel Barak; J Yang; A Gal-On (2001). Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits.  Journal of Biotechnology. 87:(1)67-82.  Abstract
  9. SHM Kim; T Azam; DY Yoon; LL Reznikov; Daniela Novick; Menachem Rubinstein; CA Dinarello (2001). Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein.  Proceedings of the National Academy of Sciences of the United States of America. 98:(6)3304-3309.  Abstract
  10. Batya Cohen; Dana Barkan; Yehoshua Levy; I Goldberg; E Fridman; J Kopolovic; Menachem Rubinstein (2001). Leptin induces angiopoietin-2 expression in adipose tissues.  Journal of Biological Chemistry. 276:(11)7697-7700.  Abstract
  11. Menachem Rubinstein; Daniela Novick; V Hurgin (2001). Transcriptional regulation of the IL-18 binding protein gene.  Journal of Leukocyte Biology. 98-98.  Abstract

2000

  1. Daniela Novick; RR Nabioullin; W Ragsdale et_al. (2000). The neutralization of type IIFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.  Journal of Interferon and Cytokine Research. 20:(11)971-982.  Abstract
  2. BL Liu; Daniela Novick; SH Kim; Menachem Rubinstein (2000). Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18.  Cytokine. 12:(10)1519-1525.  Abstract
  3. Edna Ben-Asher; V Chalifa-Caspi; Shirley Horn-Saban et_al. (2000). Harvesting the human genome: the Israeli perspective.  Israel Medical Association Journal. 2:(9)657-664.
  4. LL Reznikov; SH Kim; JY Westcott; J Frishman; G Fantuzzi; Daniela Novick; Menachem Rubinstein; CA Dinarello (2000). IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma.  Proceedings of the National Academy of Sciences of the United States of America. 97:(5)2174-2179.  Abstract
  5. SH Kim; Miriam Eisenstein; L Reznikov; G Fantuzzi; Daniela Novick; Menachem Rubinstein; CA Dinarello (2000). Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.  Proceedings of the National Academy of Sciences of the United States of America. 97:(3)1190-1195.  Abstract
  6. F Vidal-Vanaclocha; G Fantuzzi; L Mendoza et_al. (2000). IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.  Proceedings of the National Academy of Sciences of the United States of America. 97:(2)734-739.  Abstract
  7. B Almog; R Gold; Ada Dantes et_al. (2000). Leptin attenuates follicular apoptosis and accelerates the onset of puberty in imature rats.  Biology of Reproduction. 62:201-201.  Abstract

1999

  1. Dana Barkan; H Jia; Ada Dantes; L Vardimon; Abraham Amsterdam; Menachem Rubinstein (1999). Leptin modulates the glucocorticoid-induced ovarian steroidogenesis.  Endocrinology. 140:(4)1731-1738.  Abstract
  2. Daniela Novick; SH Kim; G Fantuzzi; LL Reznikov; CA Dinarello; Menachem Rubinstein (1999). Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response.  Immunity. 10:(1)127-136.  Abstract
  3. Abraham Amsterdam; D Barkin; Ada Dantes; R Sasson; YS Jung; H Hosokawa; Y Yoshida; L Vardimon; Menachem Rubinstein (1999). Leptin modulates glucocorticoid-induced ovarian steroidogenesis and apoptosis.  Biology of Reproduction. 60:169-169.  Abstract

1998

  1. Daniela Novick; SH Kim; G Fantuzzi; LL Reznikov; CA Dinarello; Menachem Rubinstein (1998). A circulating interleukin-18 binding protein: Isolation, characterization and cloning.  European Cytokine Network. 9:(3)378-378.  Abstract
  2. Menachem Rubinstein; Daniela Novick; SH Kim; G Fantuzzi; LL Reznikov; CA Dinarello (1998). A family of poxvirus-encoded homologues of the interleukin-18 binding protein.  European Cytokine Network. 9:(3)444-444.  Abstract
  3. JL Ambrus; CM Ambrus; MA Lillie; W Dembinski; K Chadha; D Novik; Menachem Rubinstein (1998). The interferon system in neoplastic and retroviral disorders.  European Cytokine Network. 9:(3)397-397.  Abstract
  4. SH Kim; Daniela Novick; G Fantuzzi; LL Reznikov; CA Dinarello; Menachem Rubinstein (1998). The interleukin-18 binding protein is a decoy receptor lacking a trans-membrane domain.  European Cytokine Network. 9:(3)440-440.  Abstract
  5. Elazar Zelzer; Yinon Levy; Chaim Kahana; Ben-Zion Shilo; Menachem Rubinstein; Batya Cohen (1998). Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1 alpha/ARNT.  EMBO Journal. 17:(17)5085-5094.  Abstract
  6. Menachem Rubinstein; CA Dinarello; JJ Oppenheim; P Hertzog (1998). Recent advances in cytokines, cytokine receptors and signal transduction.  Cytokine & Growth Factor Reviews. 9:(2)175-181.  Abstract
  7. CA Dinarello; Daniela Novick; AJ Puren et_al. (1998). Overview of interleukin-18: more than an interferon-gamma inducing factor.  Journal of Leukocyte Biology. 63:(6)658-664.  Abstract

1997

  1. SH Kim; Batya Cohen; Daniela Novick; Menachem Rubinstein (1997). Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2.  Gene. 196:(2-Jan)279-286.  Abstract
  2. JL Ambrus; S Chadha; Daniela Novick; Menachem Rubinstein; B Gopalakrishnan; Z Bernstein; RL Priore; KC Chadha (1997). Mechanism(s) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis.  Research Communications in Molecular Pathology and Pharmacology. 96:(3)255-265.  Abstract

1996

  1. Batya Cohen; Daniela Novick; Menachem Rubinstein (1996). Modulation of insulin activities by leptin.  Science. 274:(5290)1185-1188.  Abstract
  2. D Gamus; A Romano; Menachem Rubinstein; N Savion (1996). Moderation of herpetic stromal keratitis by basic fibroblast growth factor.  Experimental Eye Research. 63:(1)1-7.  Abstract
  3. D Gamus; Menachem Rubinstein; A Romano; Y BenShaul; N Savion (1996). The effect of chloroquine on HSV-induced corneal disease an in vitro and in vivo study.  Investigative Ophthalmology & Visual Science. 37:(3)207-207.  Abstract

1995

  1. P DOMANSKI; M WITTE; M KELLUM; Menachem Rubinstein; R HACKETT; P PITHA; OR COLAMONICI (1995). CLONING AND EXPRESSION OF A LONG FORM OF THE BETA-SUBUNIT OF THE INTERFERON ALPHA-BETA RECEPTOR THAT IS REQUIRED FOR SIGNALING.  Journal of Biological Chemistry. 270:(37)21606-21611.  Abstract
  2. Batya Cohen; Daniela Novick; Shmuel Barak; Menachem Rubinstein (1995). LIGAND-INDUCED ASSOCIATION OF THE TYPE-I INTERFERON RECEPTOR COMPONENTS.  Molecular and Cellular Biology. 15:(8)4208-4214.  Abstract
  3. Daniela Novick; Batya Cohen; Naama Tal; Menachem Rubinstein (1995). SOLUBLE AND MEMBRANE-ANCHORED FORMS OF THE HUMAN IFN-ALPHA/BETA RECEPTOR.  Journal of Leukocyte Biology. 57:(5)712-718.  Abstract

1994

  1. DG FISCHER; Daniela Novick; Batya Cohen; Menachem Rubinstein (1994). ISOLATION AND CHARACTERIZATION OF A SOLUBLE FORM OF THE LDL RECEPTOR, AN INTERFERON-INDUCED ANTIVIRAL PROTEIN.  Proceedings Of The Society For Experimental Biology And Medicine. 206:(3)228-232.  Abstract
  2. A ULLRICH; I SURES; M DEGIDIO et_al. (1994). THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR.  Journal of Biological Chemistry. 269:(28)18401-18407.  Abstract
  3. Daniela Novick; Batya Cohen; Menachem Rubinstein (1994). THE HUMAN INTERFERON-ALPHA/BETA RECEPTOR - CHARACTERIZATION AND MOLECULAR-CLONING.  Cell. 77:(3)391-400.  Abstract
  4. D GAMUS; A ROMANO; Menachem Rubinstein; N SAVION (1994). ATTENUATION OF HERPETIC STROMAL KERATITIS BY BFGF.  Investigative Ophthalmology & Visual Science. 35:(4)1681-1681.  Abstract

1993

  1. DG FISCHER; Naama Tal; Daniela Novick; Shmuel Barak; Menachem Rubinstein (1993). AN ANTIVIRAL SOLUBLE FORM OF THE LDL RECEPTOR-INDUCED BY INTERFERON.  Science. 262:(5131)250-253.  Abstract
  2. Menachem Rubinstein (1993). PATENT CONCERNS.  Bio-Technology. 11:(4)420-420.

1992

  1. O EDELBAUM; D STEIN; N HOLLAND; Y GAFNI; Oz Livneh; Daniela Novick; Menachem Rubinstein; Irit Sela (1992). EXPRESSION OF ACTIVE HUMAN INTERFERON-BETA IN TRANSGENIC PLANTS.  Journal of Interferon Research. 12:(6)449-453.  Abstract
  2. Daniela Novick; Batya Cohen; Menachem Rubinstein (1992). SOLUBLE INTERFERON-ALPHA RECEPTOR MOLECULES ARE PRESENT IN BODY-FLUIDS.  FEBS Letters. 314:(3)445-448.  Abstract
  3. Z REITER; A LOYTER; O NUSSBAUM; Menachem Rubinstein (1992). AN INDUCER OF NKCF (NK CYTOTOXIC FACTOR) RELEASE - LOCALIZATION ON TARGET-CELL MEMBRANE AND INITIAL CHARACTERIZATION.  Cellular Immunology. 142:(2)370-384.
  4. Z REITER; L CHEN; Michel Revel; Menachem Rubinstein (1992). INTERLEUKIN-6 PROTECTS DUCTAL BREAST-CARCINOMA CELLS FROM MHC-UNRESTRICTED CELL-MEDIATED CYTOTOXICITY.  Journal of Interferon and Cytokine Research. 11:(3)175-181.  Abstract
  5. Menachem Rubinstein; S FELDER; I LAX; M ZHOU; A ULLRICH; J SCHLESSINGER (1992). REACTIVITY OF EXTRACELLULAR DOMAINS OF THE EGF RECEPTOR BY BIOSPECIFIC INTERACTION ANALYSIS (BIA).  FASEB Journal. 6:(1)A94-A94.  Abstract

1991

  1. Z REITER; Y REITER; Z FISHELSON; M SHINITZKY; A KESSLER; A LOYTER; O NUSSBAUM; Menachem Rubinstein (1991). RESISTANCE TO NK-CELL-MEDIATED CYTOTOXICITY (IN K-562 CELLS) DOES NOT CORRELATE WITH CLASS-I MHC ANTIGEN LEVELS.  Immunobiology. 183:(2-Jan)23-39.  Abstract
  2. O EDELBAUM; N SHER; Menachem Rubinstein; Daniela Novick; Naama Tal; M MOYER; E WARD; J RYALS; Irit Sela (1991). 2 ANTIVIRAL PROTEINS, GP35 AND GP22, CORRESPOND TO BETA-1,3-GLUCANASE AND AN ISOFORM OF PR-5.  Plant Molecular Biology. 17:(1)171-173.
  3. E YONISHROUACH; Adi Kimchi; Menachem Rubinstein (1991). THE ANTIPROLIFERATIVE EFFECT OF CYCLOSPORINE ON HEMATOPOIETIC AND LYMPHOBLASTOID CELL-LINES - COMMON MECHANISTIC ELEMENTS WITH INTERFERON-ALPHA.  Transplantation. 51:(6)1276-1282.  Abstract
  4. E YONISHROUACH; DG FISCHER; Menachem Rubinstein (1991). CYCLOSPORINE-A REGULATES THE EXPRESSION OF HLA-DR ON HUMAN MONOCYTES BY 2 DIFFERENT MECHANISMS.  Cellular Immunology. 134:(2)402-413.
  5. Daniela Novick; H ENGELMANN; Michel Revel; Orith Leitner; Menachem Rubinstein (1991). MONOCLONAL-ANTIBODIES TO THE SOLUBLE HUMAN IL-6 RECEPTOR - AFFINITY PURIFICATION, ELISA, AND INHIBITION OF LIGAND-BINDING.  Hybridoma. 10:(1)137-146.  Abstract
  6. Menachem Rubinstein; Michel Revel; Daniela Novick et_al. (1991). PRODUCTION, DOWNSTREAM PROCESSING AND CHARACTERIZATION OF PROTEINS FROM RECOMBINANT ANIMAL-CELLS - THE CASE OF HUMAN INTERFERON-BETA.  Biologicals From Recombinant Microorganisms And Animal Cells: Production And Recovery. 479-486.  Abstract
  7. O MERIMSKY; Menachem Rubinstein; D FISCHER; Avihai Danon; S CHAITCHIK (1991). PHARMACOKINETICS OF RECOMBINANT INTERFERON-ALPHA-C.  Cancer Chemotherapy and Pharmacology. 27:(5)406-408.  Abstract

1990

  1. E YONISHROUACH; M SHINITZKY; Menachem Rubinstein (1990). A METHOD FOR PREPARING BIOLOGICALLY-ACTIVE AQUEOUS CYCLOSPORINE-A SOLUTIONS AVOIDING THE USE OF DETERGENTS OR ORGANIC-SOLVENTS.  Journal of Immunological Methods. 135:(2-Jan)147-153.  Abstract
  2. Arye (Arik) Harel; M FAINARU; Menachem Rubinstein; Naama Tal; Michal Schwartz (1990). FISH APOLIPOPROTEIN-A-I HAS HEPARIN BINDING-ACTIVITY - IMPLICATION FOR NERVE REGENERATION.  Journal of Neurochemistry. 55:(4)1237-1243.
  3. D LAZARD; Naama Tal; Menachem Rubinstein; Miriam Khen; Doron Lancet; K ZUPKO (1990). IDENTIFICATION AND BIOCHEMICAL-ANALYSIS OF NOVEL OLFACTORY-SPECIFIC CYTOCHROME-P-450IIA AND UDP-GLUCURONOSYL TRANSFERASE.  Biochemistry. 29:(32)7433-7440.
  4. Daniela Novick; H ENGELMANN; David Wallach; Orith Leitner; Michel Revel; Menachem Rubinstein (1990). PURIFICATION OF SOLUBLE CYTOKINE RECEPTORS FROM NORMAL HUMAN URINE BY LIGAND-AFFINITY AND IMMUNOAFFINITY CHROMATOGRAPHY.  Journal of Chromatography. 510:331-337.  Abstract
  5. Z REITER; Menachem Rubinstein (1990). INTERLEUKIN-1-ALPHA AND TUMOR NECROSIS FACTOR-ALPHA PROTECT CELLS AGAINST NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY AND NATURAL-KILLER CYTOTOXIC FACTOR.  Cellular Immunology. 125:(2)326-336.
  6. O EDELBAUM; N ILAN; G GRAFI; N SHER; Y STRAM; Daniela Novick; Naama Tal; Irit Sela; Menachem Rubinstein (1990). 2 ANTIVIRAL PROTEINS FROM TOBACCO - PURIFICATION AND CHARACTERIZATION BY MONOCLONAL-ANTIBODIES TO HUMAN BETA-INTERFERON.  Proceedings of the National Academy of Sciences of the United States of America. 87:(2)588-592.
  7. David Wallach; D ADERKA; Menachem Rubinstein; H ENGELMANN; YS AVNI; I SAROV; H HOLTMANN (1990). MECHANISMS INVOLVED IN REGULATION OF THE RESPONSE TO TUMOR-NECROSIS-FACTOR - POSSIBLE ROLES FOR PROSTAGLANDIN PRODUCTION IN SENSITIZATION TO TNF EFFECTS AND FOR A SPECIFIC TNF-BINDING PROTEIN IN PROTECTION FROM THEM.  Tumor Necrosis Factor : Structure, Mechanism Of Action, Role In Disease And Therapy. 146-155.  Abstract
  8. Daniela Novick; H ENGELMANN; David Wallach; Menachem Rubinstein (1990). SOLUBLE CYTOKINE-RECEPTORS ARE PRESENT IN NORMAL HUMAN URINE.  Physiological And Pathological Effects Of Cytokines. 10:413-421.  Abstract
  9. Daniela Novick; H ENGELMANN; Orith Leitner; David Wallach; Michel Revel; Menachem Rubinstein (1990). SOLUBLE CYTOKINE-RECEPTORS IN NORMAL HUMAN URINE - PURIFICATION, BIOLOGICAL-ACTIVITY AND MONOCLONAL-ANTIBODIES.  Lymphokine Research. 9:(4)580-580.  Abstract
  10. H ENGELMANN; D ADERKA; H HOLTMANN et_al. (1990). SOLUBLE FORMS OF THE TNF RECEPTORS, PURIFIED FROM HUMAN URINE, INHIBIT TNF EFFECTS - ANTIBODIES AGAINST THE SOLUBLE RECEPTORS INDUCE TNF-LIKE EFFECTS.  Molecular And Cellular Biology Of Cytokines. 10:299-308.  Abstract

1989

  1. Daniela Novick; H ENGELMANN; David Wallach; Menachem Rubinstein (1989). SOLUBLE CYTOKINE RECEPTORS ARE PRESENT IN NORMAL HUMAN-URINE.  Journal of Experimental Medicine. 170:(4)1409-1414.
  2. H ENGELMANN; D ADERKA; Menachem Rubinstein; D ROTMAN; David Wallach (1989). A TUMOR NECROSIS FACTOR-BINDING PROTEIN PURIFIED TO HOMOGENEITY FROM HUMAN-URINE PROTECTS CELLS FROM TUMOR NECROSIS FACTOR TOXICITY.  Journal of Biological Chemistry. 264:(20)11974-11980.
  3. Daniela Novick; DG FISCHER; Z REITER; Zelig Eshhar; Menachem Rubinstein (1989). MONOCLONAL-ANTIBODIES TO THE HUMAN INTERFERON-GAMMA RECEPTOR - BLOCKING OF THE BIOLOGICAL-ACTIVITIES OF INTERFERON-GAMMA AND PURIFICATION OF THE RECEPTOR.  Journal of Interferon Research. 9:(3)315-328.
  4. Michel Revel; A ZILBERSTEIN; L CHEN; Y GOTHELF; I BARASH; Daniela Novick; Menachem Rubinstein; R MICHALEVICZ (1989). BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2 IL-6 (ESCHERICHIA-COLI).  Annals of the New York Academy of Sciences. 557:144-156.
  5. David Wallach; H HOLTMANN; D ADERKA; Menachem Rubinstein; YS AVNI; I SAROV; H ENGELMAN (1989). MECHANISMS WHICH TAKE PART IN REGULATION OF THE RESPONSE TO TUMOR NECROSIS FACTOR.  Lymphokine Research. 8:(3)359-363.
  6. Michel Revel; A ZILBERSTEIN; L CHEN; Y GOTHELF; I BARASH; Daniela Novick; Menachem Rubinstein; R MICHALEVICZ (1989). BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2/IL-6 (ESCHERICHIA-COLI).  Regulation Of The Acute Phase And Immune Responses : Interleukin-6. 557:144-156.  Abstract

1988

  1. Y SHABO; Joseph Lotem; Menachem Rubinstein; Michel Revel; SC CLARK; SF WOLF; R KAMEN; Leo Sachs (1988). THE MYELOID BLOOD-CELL DIFFERENTIATION INDUCING PROTEIN MGI-2A IS INTERLEUKIN-6.  Blood. 72:(6)2070-2073.
  2. L CHEN; Daniela Novick; Menachem Rubinstein; Michel Revel (1988). RECOMBINANT INTERFERON-BETA-2 (INTERLEUKIN-6) INDUCES MYELOID DIFFERENTIATION.  FEBS Letters. 239:(2)299-304.
  3. Z REITER; DG FISCHER; Menachem Rubinstein (1988). THE PROTECTIVE EFFECT OF INTERFERON AGAINST NATURAL KILLING ACTIVITY IS NOT MEDIATED VIA THE EXPRESSION OF CLASS-I MHC ANTIGENS.  Immunology Letters. 17:(4)323-328.
  4. DG FISCHER; Daniela Novick; P ORCHANSKY; Menachem Rubinstein (1988). 2 MOLECULAR-FORMS OF THE HUMAN INTERFERON-GAMMA RECEPTOR - LIGAND-BINDING, INTERNALIZATION, AND DOWN-REGULATION.  Journal of Biological Chemistry. 263:(6)2632-2637.

1987

  1. DG FISCHER; Daniela Novick; Menachem Rubinstein (1987). 2 MOLECULAR-FORMS OF THE IFN-GAMMA RECEPTOR - LIGAND-BINDING, INTERNALIZATION AND DOWN REGULATION.  Journal of Interferon Research. 7:(6)765-765.  Abstract
  2. Daniela Novick; Menachem Rubinstein; DG FISCHER (1987). ANTIIDIOTYPIC ANTIBODIES TO THE IDIOTYPES OF ANTI-INTERFERON-GAMMA ALPHA-ANTIBODIES AND BETA-ANTIBODIES AS PROBES TO STUDY THE IFN RECEPTOR.  Journal of Interferon Research. 7:(6)769-769.  Abstract
  3. Michel Revel; A ZILBERSTEIN; RM RUGGIERI; Menachem Rubinstein; L CHEN (1987). AUTOCRINE INTERFERONS AND INTERFERON-BETA-2.  Journal of Interferon Research. 7:(5)529-536.
  4. Menachem Rubinstein (1987). MULTIPLE INTERFERON SUBTYPES - THE PHENOMENON AND ITS RELEVANCE.  Journal of Interferon Research. 7:(5)545-551.
  5. Menachem Rubinstein; Tal Goren; DG FISCHER (1987). CHARACTERIZATION OF HUMAN INTERFERONS BY HPLC.  Reactive Polymers. 6:(3-Feb)342-342.  Abstract
  6. Daniela Novick; P ORCHANSKY; Michel Revel; Menachem Rubinstein (1987). THE HUMAN INTERFERON-GAMMA RECEPTOR - PURIFICATION, CHARACTERIZATION, AND PREPARATION OF ANTIBODIES.  Journal of Biological Chemistry. 262:(18)8483-8487.
  7. Menachem Rubinstein; Daniela Novick; DG FISCHER (1987). THE HUMAN INTERFERON-GAMMA RECEPTOR SYSTEM.  Immunological Reviews. 97:29-50.
  8. Menachem Rubinstein; P ORCHANSKY; DG FISCHER; Daniela Novick (1987). THE HUMAN INTERFERON-GAMMA RECEPTOR.  Investigational New Drugs. 5:(1)91-91.  Abstract

1986

  1. Tal Goren; DG FISCHER; Menachem Rubinstein (1986). HUMAN-MONOCYTES AND LYMPHOCYTES PRODUCE DIFFERENT MIXTURES OF ALPHA-INTERFERON SUBTYPES.  Journal of Interferon Research. 6:(4)323-329.
  2. DG FISCHER; Menachem Rubinstein (1986). HUMAN-MONOCYTES TUMORICIDAL ACTIVITY - THE ROLE OF INTERFERON-GAMMA AND BACTERIAL LIPOPOLYSACCHARIDE IN ITS STIMULATION, PRESERVATION AND DECAY.  Immunobiology. 172:(2-Jan)110-119.
  3. Tal Goren; DG FISCHER; Menachem Rubinstein (1986). PRIMING OF LEUKOCYTES SELECTIVELY INCREASES THE LEVEL OF SOME INTERFERON-ALPHA SUBTYPES AND NOT OTHERS.  Biochimica Et Biophysica Acta. 887:(1)80-85.
  4. Yochanan Mizrachi; Menachem Rubinstein; Y KIMHI; Michal Schwartz (1986). A NEUROTROPHIC FACTOR DERIVED FROM GOLDFISH BRAIN - CHARACTERIZATION AND PURIFICATION.  Journal of Neurochemistry. 46:(6)1675-1682.
  5. Y MORY; J BENBARAK; D SEGEV et_al. (1986). EFFICIENT CONSTITUTIVE PRODUCTION OF HUMAN IFN-GAMMA IN CHINESE-HAMSTER OVARY CELLS.  Dna-A Journal Of Molecular & Cellular Biology. 5:(3)181-193.
  6. P ORCHANSKY; Menachem Rubinstein; DG FISCHER (1986). THE INTERFERON-GAMMA RECEPTOR IN HUMAN-MONOCYTES IS DIFFERENT FROM THE ONE IN NONHEMATOPOIETIC CELLS.  Journal of Immunology. 136:(1)169-173.
  7. Menachem Rubinstein; P ORCHANSKY (1986). THE INTERFERON RECEPTORS.  Crc Critical Reviews In Biochemistry. 21:(3)249-275.
  8. Menachem Rubinstein; DG FISCHER; P ORCHANSKY (1986). MULTIPLE HUMAN INTERFERON-GAMMA RECEPTORS.  Journal of Cellular Biochemistry. 222-222.  Abstract

1985

  1. H ROSENBERG; Z MADAR; A GERTLER; Menachem Rubinstein; T BINO (1985). THE FATE OF [I-125]-LABELED HUMAN LEUKOCYTE-DERIVED ALPHA INTERFERON IN THE RAT.  Journal of Interferon Research. 5:(1)121-127.
  2. Y MORY; J BENBARAK; D SEGEV; Batya Cohen; Daniela Novick; DG FISCHER; Menachem Rubinstein; Michel Revel (1985). EFFICIENT CONSTITUTIVE PRODUCTION OF HUMAN IFN-GAMMA IN MAMMALIAN-CELLS.  Dna-A Journal Of Molecular & Cellular Biology. 4:(1)80-80.  Abstract

1984

  1. Y CHERNAJOVSKY; Y MORY; L CHEN; Z MARKS; Daniela Novick; Menachem Rubinstein; Michel Revel (1984). EFFICIENT CONSTITUTIVE PRODUCTION OF HUMAN FIBROBLAST INTERFERON BY HAMSTER-CELLS TRANSFORMED WITH THE IFN-BETA-1 GENE FUSED TO AN SV40 EARLY PROMOTER.  Dna-A Journal Of Molecular & Cellular Biology. 3:(4)297-308.
  2. D PLAN; Menachem Rubinstein; Michel Revel; M DEFAYOLLE; M MUSSET; H VUVAN; D FIERE (1984). INVITRO PRODUCTION OF INTERFERON-ALPHA BY THE LEUKOCYTES OF PATIENTS WITH LEUKEMIA.  Annales de Virologie. 135:(3)307-308.  Abstract
  3. M FINEL; Menachem Rubinstein; Uri Pick (1984). PREPARATION OF AN EPSILON-DEFICIENT CHLOROPLAST COUPLING FACTOR-I HAVING A HIGH ATPASE ACTIVITY.  FEBS Letters. 166:(1)85-89.
  4. J FRIEDLANDER; DG FISCHER; Menachem Rubinstein (1984). ISOLATION OF 2 DISCRETE HUMAN INTERFERON-GAMMA (IMMUNE) SUBTYPES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY.  Analytical Biochemistry. 137:(1)115-119.
  5. P ORCHANSKY; Daniela Novick; DG FISCHER; Menachem Rubinstein (1984). TYPE-I AND TYPE-II INTERFERON RECEPTORS.  Journal of Interferon Research. 4:(2)275-282.

1983

  1. Daniela Novick; Zelig Eshhar; DG FISCHER; J FRIEDLANDER; Menachem Rubinstein (1983). MONOCLONAL-ANTIBODIES TO HUMAN INTERFERON-GAMMA - PRODUCTION, AFFINITY PURIFICATION AND RADIOIMMUNOASSAY.  EMBO Journal. 2:(9)1527-1530.
  2. Daniela Novick; Zelig Eshhar; O GIGI; Z MARKS; Michel Revel; Menachem Rubinstein (1983). AFFINITY-CHROMATOGRAPHY OF HUMAN FIBROBLAST INTERFERON (IFN-BETA 1) BY MONOCLONAL-ANTIBODY COLUMNS.  Journal of General Virology. 64:(APR)905-910.
  3. Tal Goren; Aviva Kapitkovsky; Adi Kimchi; Menachem Rubinstein (1983). HIGH AND LOW POTENCY INTERFERON-ALPHA SUBTYPES INDUCE (2'-5') OLIGOADENYLATE SYNTHETASE WITH SIMILAR EFFICIENCY.  Virology. 130:(2)273-280.
  4. DG FISCHER; Menachem Rubinstein (1983). SPONTANEOUS PRODUCTION OF INTERFERON-GAMMA AND ACID-LABILE INTERFERON-ALPHA BY SUBPOPULATIONS OF HUMAN MONONUCLEAR-CELLS.  Cellular Immunology. 81:(2)426-434.

1982

  1. Daniela Novick; Zelig Eshhar; Menachem Rubinstein (1982). MONOCLONAL-ANTIBODIES TO HUMAN ALPHA-INTERFERON AND THEIR USE FOR AFFINITY-CHROMATOGRAPHY.  Journal of Immunology. 129:(5)2244-2247.
  2. Marc Fellous; U NIR; David Wallach; G MERLIN; Menachem Rubinstein; Michel Revel (1982). INTERFERON-DEPENDENT INDUCTION OF MESSENGER-RNA FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS IN HUMAN-FIBROBLASTS AND LYMPHOBLASTOID-CELLS.  Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79:(10)3082-3086.
  3. Menachem Rubinstein (1982). PURIFICATION AND STRUCTURAL-ANALYSIS OF INTERFERON.  PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 299:(1094)39-50.
  4. Menachem Rubinstein (1982). THE STRUCTURE OF HUMAN INTERFERONS.  Biochimica Et Biophysica Acta. 695:(1)5-16.
  5. P ORCHANSKY; Menachem Rubinstein; Irit Sela (1982). HUMAN INTERFERONS PROTECT PLANTS FROM VIRUS-INFECTION.  Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79:(7)2278-2280.

1977

  1. Yoram Shechter; Menachem Rubinstein; Abraham Patchornik (1977). SELECTIVE COVALENT BINDING OF METHIONYL-CONTAINING PEPTIDES AND PROTEINS TO WATER INSOLUBLE POLYMERIC REAGENT AND THEIR REGENERATION.  Biochemistry. 16:(7)1424-1430.

1976

  1. Menachem Rubinstein; Yoram Shechter; Abraham Patchornik (1976). COVALENT CHROMATOGRAPHY - ISOLATION OF TRYPTOPHANYL CONTAINING PEPTIDES BY NOVEL POLYMERIC REAGENTS.  Biochemical and Biophysical Research Communications. 70:(4)1257-1263.

1975

  1. Menachem Rubinstein; Abraham Patchornik (1975). POLY(3,5-DIETHYLSTYRENE) SULFONYL CHLORIDE - NEW REAGENT FOR INTERNUCLEOTIDE BOND SYNTHESIS.  Tetrahedron. 31:(13-1)1517-1519.
  2. Yoram Shechter; Menachem Rubinstein; R BECKER; Z BOHAK (1975). MODULATION OF ENZYMIC ACTIVITY OF CHICKEN PEPSIN BY COVALENT MODIFICATION OF ITS SINGLE - SH-GROUP.  FEBS Journal. 58:(1)123-131.
  3. Menachem Rubinstein; B AMIT; Abraham Patchornik (1975). USE OF A LIGHT-SENSITIVE PHOSPHATE PROTECTING GROUP FOR SOME MONONUCLEOTIDE SYNTHESES.  Tetrahedron Letters. (17)1445-1448.
  4. Menachem Rubinstein; Abraham Patchornik (1975). NOVEL METHOD FOR PHOSPHODIESTER AND INTERNUCLEOTIDE BOND SYNTHESIS.  Tetrahedron. 31:(17)2107-2110.